-

Promaxo Announces Participation at the Oppenheimer 32nd Annual Healthcare Conference

OAKLAND, Calif.--(BUSINESS WIRE)--Promaxo, Inc. (“Promaxo” or the “Company”), a medical imaging, robotics, and AI technology company, today announced Amit Vohra, PhD, President and Chief Executive Officer, will participate at the Oppenheimer 32nd Annual Healthcare Conference.

Promaxo will give a virtual corporate presentation on Tuesday, March 15, 2022 at 4:40pm ET and host investor 1x1 meetings, which can be requested through Oppenheimer.

About Promaxo, Inc.

Promaxo was founded by a team of entrepreneurs and healthcare innovators to develop a minimally-invasive and patient-centric MRI and robotic platform. Based in Oakland, California, and backed by over 200 patents, the Company’s mission is to improve lives through state-of-the-art medical imaging, robotics and AI capabilities. With a compact and adaptable MRI, Promaxo is redefining the standard of care by improving the quality and speed of patient diagnosis and interventions. The Company has formed numerous long-term and strategic partnerships with investor groups and corporation as it drives commercialization of the Promaxo MRI system.

To learn more about the technology behind the MRI system and its scope, please visit: Promaxo.com.

LinkedIn: Promaxo
Twitter: @Promaxo
Facebook: Promaxo

Contacts

Investors
Gilmartin Group
Vivian Cervantes
e: IR@promaxo.com

Industry:

Promaxo, Inc.

Details
Headquarters: OAKLAND, CA
CEO: Amit Vohra
Employees: 20
Organization: PRI
Release Summary
Promaxo will present at the Oppenheimer 32nd Annual Healthcare Conference on Tuesday, March 15, 2022 at 4:40pm ET and host investor 1x1 meetings
Release Versions
English

Contacts

Investors
Gilmartin Group
Vivian Cervantes
e: IR@promaxo.com

Social Media Profiles
Connect with us Facebook
Connect with us on LinkedIn
Connect with us Twitter
More News From Promaxo, Inc.

Promaxo Expands Presence with Opening of New Office in Belgium

OAKLAND, Calif.--(BUSINESS WIRE)--Promaxo, Inc. (“Promaxo” or the “Company”), a medical imaging, robotics, and AI technology company, today announced the opening of its new office, Promaxo BV, in Bruges, Belgium and the appointment of Pete Zaudtke as the Head of its European office. “We are excited to expand our presence and enter Europe, with the opening of Promaxo BV, headquartered in Bruges, Belgium. From this launching pad, we look forward to initiating clinical studies, and developing regu...

Promaxo Announces Sale of In-Office MRI to Kasraeian Urology

OAKLAND, Calif.--(BUSINESS WIRE)--Promaxo, Inc. (“Promaxo” or the “Company”), a medical imaging, robotics, and AI technology company, announced today the sale of its in-office MRI system to Kasraeian Urology, a Division of Florida Physician Specialists (“Kasraeian Urology”). FDA cleared for in-office use, the Company’s single-sided MRI system with AI based imaging empowers practices and hospitals to accurately and seamlessly guide prostate interventions under the Promaxo scanner. “Our technolog...

Promaxo Announces Participation in the Piper Sandler 33rd Annual Virtual Healthcare Conference

OAKLAND, Calif.--(BUSINESS WIRE)--Promaxo, Inc. (“Promaxo” or the “Company”), a medical imaging, robotics, and AI technology company, today announced Amit Vohra, Chief Executive Officer, will participate at the Piper Sandler 33rd Annual Virtual Healthcare Conference from November 22 to December 2, 2021. Promaxo will give a corporate presentation and host investor 1x1 meetings, which can be requested through Piper Sandler. About Promaxo, Inc. Promaxo was founded by a team of entrepreneurs and he...
Back to Newsroom